Peripheral IV Catheters Market Report 2026

The peripheral iv catheters market size has grown strongly in recent years. It will grow from $5.74 billion in 2025 to $6.29 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to high incidence of hospital-acquired infections, reliance on conventional IV catheters, growing patient population requiring iv, limited availability of advanced safety catheters, fragmented healthcare infrastructure.

The peripheral iv catheters market size is expected to see strong growth in the next few years. It will grow to $9.01 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to advancements in safety iv catheter technologies, increasing adoption of smart and antimicrobial catheters, expansion of home healthcare services, rising preference for integrated/closed iv systems, growing demand for minimally invasive therapy administration. Major trends in the forecast period include increasing adoption of ai-based catheter insertion guidance systems, rising use of cloud-based patient monitoring for iv therapy, growing development of antimicrobial and smart catheters, increasing integration of iot-enabled devices for iv monitoring, rising implementation of smart manufacturing for peripheral iv catheters.

The increasing prevalence of chronic diseases is expected to drive the growth of the peripheral IV catheters market in the coming years. Peripheral intravenous catheters are widely used in the treatment and management of chronic conditions such as cancer, cardiovascular diseases, and other long-term illnesses. The rise in chronic diseases is largely attributed to sedentary lifestyles, which reduce physical activity and increase the risk of developing long-term health conditions. Peripheral IV catheters play a critical role in chronic disease management by providing reliable vascular access for the continuous administration of medications, fluids, and therapeutic agents required to manage these conditions effectively. For instance, in 2025, according to the Northern Arizona Medical Group, a US-based healthcare provider, nearly three-quarters of the global population is projected to live with at least one chronic illness, with prevalence continuing to rise significantly. In the United States, data from 2023 showed that approximately 76.4% of adults had at least one chronic condition, while 51.4% reported having two or more. Therefore, the rising burden of chronic diseases is contributing to the expansion of the peripheral IV catheters market.

Major companies operating in the peripheral IV catheters market are focusing on the development of innovative technologies such as multi-access blood control septums to improve catheter safety and performance. A multi-access blood control septum is a valve integrated into the catheter hub that automatically prevents blood leakage when the hub is accessed, eliminating the need for manual vein occlusion. This innovation allows multiple line connections while maintaining a closed system and enhancing clinician safety. For example, in July 2024, B. Braun Melsungen AG, a Germany-based manufacturer specializing in infusion therapy devices, announced that the US Food and Drug Administration granted approval for the Introcan Safety® 2 Deep Access IV Catheter. This product incorporates a multi-access blood control septum designed to prevent blood leakage during hub access, reduce contamination risk during repeated connections and disconnections, and improve overall safety for healthcare professionals.

In May 2025, ICU Medical Inc., a US-based manufacturer of vascular access devices and infusion therapy consumables, entered into a joint venture with Otsuka Pharmaceutical Factory Inc. to strengthen the IV solutions and infusion therapy market. Through this partnership, the companies formed Otsuka ICU Medical LLC, combining Otsuka Pharmaceutical Factory’s extensive global IV solutions manufacturing capabilities across Asia with ICU Medical’s North American production capacity, distribution network, and infusion therapy expertise. This collaboration aims to enhance supply chain resilience, ensure a stable large-scale supply of IV solutions, and introduce new PVC-free IV technologies to the North American market, thereby supporting the growth of the broader peripheral IV catheter and infusion therapy market.

Major companies operating in the peripheral iv catheters market are Becton, Dickinson and Company, B. Braun Melsungen AG, Smiths Medical Inc., Vygon SAS, Terumo Corporation, Teleflex Incorporated, NIPRO Medical Corporation, Argon Medical Devices Inc., Medical Components Inc., Vascular Pathways Inc., Tangent Medical Technologies Inc., Vigmed AB, Venner Medical, C. R. Bard Inc., MedSource Labs, Intra Special Catheters GmbH, Greiner Bio-One International GmbH, Ares Medikal, Ace Medical Company, Heka s.r.l, Raumedic AG, Vogt Medical Vertrieb GmbH, RenovoRx Inc., Retractable Technologies Inc., AngioDynamics Inc., ICU Medical Inc., Medtronic plc, Edwards Lifesciences Corporation, Cook Group Incorporated, Stryker Corporation, Boston Scientific Corporation, Johnson & Johnson, Abbott Laboratories, Merit Medical Systems Inc.

North America was the largest region in the peripheral IV catheters market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral iv catheters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the peripheral iv catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have impacted the peripheral iv catheters market by increasing costs of imported catheters, smart devices, and antimicrobial components, particularly in North America and Europe. This has temporarily slowed adoption in hospitals and clinics, while also encouraging domestic manufacturing, promoting innovation in cost-effective safety and smart catheter solutions, and strengthening supply chain resilience across healthcare delivery channels.

The peripheral iv catheters market research report is one of a series of new reports that provides peripheral iv catheters market statistics, including peripheral iv catheters industry global market size, regional shares, competitors with a peripheral iv catheters market share, detailed peripheral iv catheters market segments, market trends and opportunities, and any further data you may need to thrive in the peripheral iv catheters industry. This peripheral iv catheters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Peripheral IV catheters are thin, flexible tubes inserted into a vein to administer medications, fluids, nutritional supplements, or blood products. Peripheral intravenous catheters are also commonly used for blood sampling and other therapeutic purposes in clinical care settings.

The main types of peripheral IV catheters include short peripheral intravenous catheters and integrated or closed peripheral intravenous catheters. Short peripheral catheters are typically less than three inches in length. The technologies used in peripheral IV catheters include conventional peripheral intravenous catheters and safety peripheral intravenous catheters, which are designed to reduce needlestick injuries. These devices are used across various end-user settings such as hospitals, clinics, ambulatory surgical centers, and home healthcare environments.

The peripheral IV catheters market consists of sales of long peripheral intravenous catheters (long PIVC), and midline catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.